Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Groot, S. de
(-)
= Portielje, J.E.A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(5)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(1)
+
-
Creation Date
2020
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Topic
toxicity
(2)
+
-
Author
Groot, S. de
(5)
+
-
Kroep, J.R.
(5)
+
-
Pijl, H.
(4)
+
-
Fischer, M.J.
(3)
+
-
Heijns, J.B.
(3)
+
-
Hoeven, J.J.M. van der
(3)
+
-
Imholz, A.L.T.
(3)
+
-
Kessels, L.W.
(3)
+
-
Lugtenberg, R.T.
(3)
+
-
Baars, A.
(2)
+
-
Cohen, D.
(2)
+
-
Duijm-de Carpentier, M.
(2)
+
-
Dutch Breast Canc Res Grp BOOG
(2)
+
-
Fiocco, M.
(2)
+
-
Gelderblom, H.
(2)
+
-
Graaf, H. de
(2)
+
-
Kaptein, A.A.
(2)
+
-
Kranenbarg, E.M.K.
(2)
+
-
Longo, V.D.
(2)
+
-
Putter, H.
(2)
+
-
Smit, V.T.H.B.M.
(2)
+
-
Vreeswijk, M.P.G.
(2)
+
-
Vrijaldenhoven, S.
(2)
+
-
Wouw, A.J. van de
(2)
+
-
Show more
Language
en
(5)
+
-
Search results
(1 - 5 of 5)
show grid
show list
save search
Phase 1 study to evaluate the safety of reducing the prophylactic dose of dexamethasone around docetaxel infusion in patients with prostate and breast cancer
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial
Fasting mimicking diet as an adjunct toneoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients
DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer